Clinical Trial: Domperidone in Refractory Gastroparesis
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Domperidone in Refractory Gastroparesis
Brief Summary: The primary objective of this study is to prescribe oral domperidone for patients with gastroparesis who have failed or suffered adverse effects from standard medical therapy.
Detailed Summary:
Sponsor: Yale University
Current Primary Outcome: Improvement in Gastroparesis Cardinal Symptom Index [ Time Frame: upon study completion ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Yale University
Dates:
Date Received: September 24, 2008
Date Started: October 2008
Date Completion:
Last Updated: June 21, 2016
Last Verified: June 2016